Online citations, reference lists, and bibliographies.
← Back to Search

Mesotelioma Pleural Maligno

E. M. G. Atienza, C. L. V. Jiménez, S. N. Ruiz, J. Hidalgo
Published 2017 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Resumen El mesotelioma maligno es un tumor agresivo de superficies serosas cuya frecuencia esta aumentando en todo el mundo, probablemente en relacion con la exposicion extendida de la poblacion a asbesto, principal factor de riesgo con el que se ha asociado. El tratamiento actual incluye: cirugia (pleurectomia o neumonectomia extrapleural) seguida de radioterapia, aunque recientemente se ha anadido el uso de quimioterapia. El tratamiento paliativo puede contribuir a mejorar la calidad de vida y a alcanzar un buen control sintomatico durante anos tras el diagnostico. A continuacion presentamos un caso representativo de mesotelioma.
This paper references
10.1200/JCO.2003.11.136
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.
N. Vogelzang (2003)
10.1002/14651858.CD002916.PUB2
Pleurodesis for malignant pleural effusions.
P. Shaw (2004)
10.1043/1543-2165(2008)132[397:AOITTD]2.0.CO;2
Application of immunohistochemistry to the diagnosis of malignant mesothelioma.
A. Marchevsky (2008)
10.1016/J.CCM.2006.01.004
Management of malignant pleural mesothelioma.
S. West (2006)
R.Active symptom control with or without mesothelioma chemotherapy in the treatment of patients with malignant pleural (MS01): a multicenter randomized trial
M Muers (2008)
10.1016/S0022-5223(99)70469-1
Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.
D. Sugarbaker (1999)
10.1016/S0304-5412(10)70267-5
Enfermedades pleurales malignas
José Martín Juan (2010)
10.1056/NEJMRA050152
Advances in malignant mesothelioma.
B. Robinson (2005)
10.1067/MTC.2001.116560
A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.
V. Rusch (2001)
10.1186/1750-1172-3-34
Malignant mesothelioma
A. Moore (2008)
Projections of asbestos-related disease 1980-2009.
A. Walker (1983)
10.1007/s11864-008-0070-4
Diagnosis, Staging, and Surgical Treatment of Malignant Pleural Mesothelioma
M. Kent (2008)
10.2169/INTERNALMEDICINE.47.0348
Presence of malignant mesothelial cells in the sputum.
Y. H. Choi (2008)
10.1177/107327480601300402
Malignant pleural mesothelioma: a comprehensive review.
R. Ismail-Khan (2006)
10.1200/JCO.1998.16.1.145
Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience.
D. Curran (1998)
10.1200/JCO.2008.20.3943
Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma.
L. Krug (2009)
10.1093/JNCI/78.6.1053
Demographic patterns for mesothelioma in the United States.
R. Connelly (1987)
Latency periods in asbestos-related mesothelioma of the pleura.
C. Bianchi (1997)
Active symptom control with or without mesothelioma chemotherapy in the treatment of patients with malignant pleural ( MS 01 ) : a multicenter randomized trial
M Muers (2008)
10.1586/14737140.8.2.293
Current concepts in malignant pleural mesothelioma
A. Kaufman (2008)
10.1016/S0300-2896(04)75506-4
Mesotelioma pleural: experiencia durante 9 años y descripción de 62 casos
V. Garrido (2004)
10.1016/J.JTCVS.2004.02.021
Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies.
D. Sugarbaker (2004)
10.1183/09031936.00063109
Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma
A. Scherpereel (2009)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar